When implanted into mice, the “pseudo-islets” helped treat the animals’ diabetes symptoms.

The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.

Scientists engineered human cells to produce a molecule that stimulates insulin secretion in the presence of caffeine.

One patient with diabetes was able to reduce his medication use while receiving targeted electrical pulses.

A study of more than 450,000 people finds a certain genetic variant associated with eating more carbs is linked to a thicker waist and higher blood pressure, but less fat.  

The new classification system could help improve personalized medicine approaches to the disease.

Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.

A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

A small patch of engineered cells makes an enzyme that stimulates insulin release.